{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:44:47Z","timestamp":1792784687550,"version":"4.5.0"},"reference-count":43,"publisher":"American Chemical Society (ACS)","issue":"37","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503555"],"award-info":[{"award-number":["82503555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26H300005"],"award-info":[{"award-number":["LQN26H300005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Project of Zhejiang Chinese Medical University","award":["2025JKZKTS47"],"award-info":[{"award-number":["2025JKZKTS47"]}],"id":[{"id":"https:\/\/ror.org\/04epb4p87","id-type":"ROR","asserted-by":"crossref"}]},{"name":"First Affiliated Hospital of Nanjing Medical University","award":["PY2022058"],"award-info":[{"award-number":["PY2022058"]}],"id":[{"id":"https:\/\/ror.org\/04py1g812","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical and Health Science Program of Zhejiang Province","award":["2025HY0538"],"award-info":[{"award-number":["2025HY0538"]}]},{"name":"?Renhe Youbo? talent plan of Zhejiang Provincial Hospital of Traditional Chinese Medicine"},{"name":"Hainan Hongji Medical Development Foundation","award":["HJ2025120908"],"award-info":[{"award-number":["HJ2025120908"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) tends to exhibit extremely large rates of tumor recurrence and mortality owing to the absence on effective therapeutic targets. Paclitaxel is the chemotherapeutic drug of choice, but the clinical efficacy in TNBC is limited. In the present study, we developed a folic acid (FA)-modified red blood cell membrane biomimetic drug delivery system encapsulating both paclitaxel and artesunate (PA@LRM-FA) against TNBC, aimed at enhancing ferroptosis and promoting immunogenic cell death to improve paclitaxel efficacy. The morphology, particle size, zeta potential, particle stability, paclitaxel and artesunate loading capacity, and paclitaxel and artesunate encapsulation efficiency of the formulations were studied. Through a cellular assay, we discovered that PA@LRM-FA inhibited the 4T1 cell proliferation, induced ROS accumulation, and promoted ferroptosis and immunogenic cell death. In tumor-bearing mice, PA@LRM-FA effectively targeted tumor tissues for the delivery of paclitaxel and artesunate and significantly induced ferroptosis, promoting immunogenic cell death and active immune cells in 4T1 tumors, resulting in a marked inhibition of tumor growth. Taken together, this work demonstrated a feasible therapeutic approach to inhibit TNBC by enhancing tumor ferroptosis and immunogenic cell death through PA@LRM-FA delivery of paclitaxel and artesunate.<\/jats:p>","DOI":"10.1021\/acsami.6c13085","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:01:32Z","timestamp":1789027292000},"page":"50555-50569","source":"Crossref","is-referenced-by-count":0,"title":["Functionalized Red Blood Cell Membrane Nanoplatform for Paclitaxel and Artesunate Induces Ferroptosis and Immunogenic Cell Death against Triple-Negative Breast Cancer"],"prefix":"10.1021","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-274X","authenticated-orcid":true,"given":"Kaiming","family":"Li","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaole","family":"Zhu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Nanjing Medical University , , ,","place":["Nanjing, China, 210029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisi","family":"Wu","sequence":"additional","affiliation":[{"name":"Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences , , ,","place":["Shenzhen, China, 518055"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Cai","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Shi","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang University School of Medicine , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyang","family":"Xie","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-5701","authenticated-orcid":true,"given":"Rui","family":"Xie","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , , ,","place":["Hangzhou, China, 310000"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026100820075572700_cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218350","article-title":"Reprogramming the Immune Microenvironment in Triple-Negative Breast Cancer with mRNA Therapeutics","volume":"645","author":"Verma","year":"2026","journal-title":"Cancer Lett."},{"issue":"8","key":"2026100820075572700_cit2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.annonc.2021.05.801","article-title":"Primary Results from IMpassion131, a Double-Blind, Placebo-Controlled, Randomised Phase III Trial of First-Line Paclitaxel with or without Atezolizumab for Unresectable Locally Advanced\/Metastatic Triple-Negative Breast Cancer","volume":"32","author":"Miles","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"2026100820075572700_cit3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-023-02677-x","article-title":"Toripalimab Plus Nab-paclitaxel in Metastatic or Recurrent Triple-Negative Breast Cancer: a Randomized Phase 3 Trial","volume":"30","author":"Jiang","year":"2024","journal-title":"Nat. Med."},{"key":"2026100820075572700_cit4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.can-22-2709","article-title":"Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer","volume":"83","author":"Liao","year":"2023","journal-title":"Cancer Res."},{"issue":"10257","key":"2026100820075572700_cit5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant Atezolizumab in Combination with Sequential Nab-paclitaxel and Anthracycline-Based Chemotherapy vs Placebo and Chemotherapy in Patients with Early-Stage Triple-Negative Breast Cancer (IMpassion031): a Randomised, Double-Blind, Phase 3 Trial","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"2026100820075572700_cit6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.annonc.2022.01.009","article-title":"Long-Term Efficacy and Safety of Addition of Carboplatin with or without Veliparib to Standard Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: 4-Year Follow-up Data from BrighTNess, a Randomized Phase III trial","volume":"33","author":"Geyer","year":"2022","journal-title":"Ann. Oncol."},{"issue":"34","key":"2026100820075572700_cit7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba8968","article-title":"Synthetic Lethal Combination Targeting BET Uncovered Intrinsic Susceptibility of TNBC to Ferroptosis","volume":"6","author":"Verma","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"2026100820075572700_cit8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2022.11.014","article-title":"The Achilles Heel of TNBCs Ferroptosis Heterogeneity","volume":"35","author":"Jiang","year":"2023","journal-title":"Cell Metab."},{"key":"2026100820075572700_cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101977","article-title":"Ent-Kaurane Diterpenoids Induce Apoptosis and Ferroptosis Through Targeting Redox Resetting to Overcome Cisplatin Resistance","volume":"43","author":"Sun","year":"2021","journal-title":"Redox Biol."},{"key":"2026100820075572700_cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217232","article-title":"The Deubiquitinase OTUD5 Stabilizes SLC7A11 to Promote Progression and Reduce Paclitaxel Sensitivity in Triple-Negative Breast Cancer","volume":"604","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"2026100820075572700_cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117292","article-title":"Artesunate-Multiple Pharmacological Effects Beyond Treating Malaria","volume":"286","author":"Chang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"2026100820075572700_cit12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","article-title":"Artesunate Sensitizes Human Hepatocellular Carcinoma to Sorafenib via Exacerbating AFAP1L2-SRC-FUNDC1 Axis-Dependent Mitophagy","volume":"20","author":"Ma","year":"2024","journal-title":"Autophagy"},{"issue":"2","key":"2026100820075572700_cit13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate Synergizes with Sorafenib to Induce Ferroptosis in Hepatocellular Carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"2026100820075572700_cit14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s42114-025-01402-1","article-title":"Functional Artemisinin Derivative-Engineered Nanohybrids Boost Ferroptosis Stress-Driven Cancer Therapy","volume":"8","author":"Wang","year":"2025","journal-title":"Adv. Compos. Hybrid Mater."},{"issue":"16","key":"2026100820075572700_cit15","doi-asserted-by":"publisher","first-page":"20143","DOI":"10.1021\/acsami.4c00558","article-title":"Dendritic Polylysine with Paclitaxel and Triptolide Codelivery for Enhanced Cancer Ferroptosis through the Accumulation of ROS","volume":"16","author":"Wen","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"47","key":"2026100820075572700_cit16","doi-asserted-by":"publisher","first-page":"32403","DOI":"10.1021\/jacs.4c08304","article-title":"Ferroptosis to Pyroptosis Regulation by Iron-Based Nanocatalysts for Enhanced Tumor Immunotherapy","volume":"146","author":"Feng","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026100820075572700_cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110108","article-title":"The Emerging Role of Ferroptosis in Inflammation","volume":"127","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"2026100820075572700_cit18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/pharmaceutics14030504","article-title":"Recent Advances in the Therapeutic Efficacy of Artesunate","volume":"14","author":"Ruwizhi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"2026100820075572700_cit19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","article-title":"Liposomal Paclitaxel Formulations","volume":"163","author":"Koudelka","year":"2012","journal-title":"J. Control. Release"},{"issue":"9","key":"2026100820075572700_cit20","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A Versatile Antibody Capture System Drives Specific in vivo Delivery of mRNA-Loaded Lipid Nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"2026100820075572700_cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121539","article-title":"A Mouse Model for Studying the Effect of Blood Anti-PEG IgMs Levels on the Fate of PEGylated Liposomes","volume":"615","author":"El Sayed","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"4","key":"2026100820075572700_cit22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s43018-026-01125-2","article-title":"Eythrocyte-Anti-PD1 Conjugates in Persons with Advanced Solid Tumors Resistant to Anti-PD1\/PDL1: Preclinical Characterization and Results of a Phase 1 Trial","volume":"7","author":"Nie","year":"2026","journal-title":"Nat. Cancer"},{"issue":"842","key":"2026100820075572700_cit23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ady6730","article-title":"In vivo Generation of CAR Myeloid Cells Through Erythrocyte-Mediated mRNA Delivery for Cancer Immunotherapy","volume":"18","author":"Nie","year":"2026","journal-title":"Sci. Transl. Med."},{"issue":"45","key":"2026100820075572700_cit24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507864","article-title":"Tumor-Targeted FABP5\/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma","volume":"12","author":"Tang","year":"2025","journal-title":"Adv. Sci."},{"key":"2026100820075572700_cit25","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1016\/j.cell.2026.02.023","article-title":"Transplantation of Encapsulated Mitochondria Alleviates Dysfunction in Mitochondrial and Parkinson's Disease Models","volume":"189","author":"Du","year":"2026","journal-title":"Cell"},{"key":"2026100820075572700_cit26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/pharmaceutics11080381","article-title":"Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications","volume":"11","author":"Kumar","year":"2019","journal-title":"Pharmaceutics"},{"issue":"50","key":"2026100820075572700_cit27","doi-asserted-by":"publisher","first-page":"33875","DOI":"10.1021\/acsnano.4c07074","article-title":"Biomimetic Nanovesicles Synergize with Short-Term Fasting for Enhanced Chemotherapy of Triple-Negative Breast Cancer","volume":"18","author":"Chiang","year":"2024","journal-title":"ACS Nano"},{"key":"2026100820075572700_cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123289","article-title":"Hybrid Cell Membrane Coating Orchestrates Foreign-Body Reactions, Anti-adhesion, and Pro-regeneration in Abdominal Wall Reconstruction","volume":"321","author":"Yang","year":"2025","journal-title":"Biomaterials"},{"key":"2026100820075572700_cit29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jconrel.2025.02.012","article-title":"A Rapamycin-Loading Platelet Membrane Hybrid Liposome with Anti-inflammation Effect and Long-Lasting Repair Capability for Acute Kidney Injury","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"issue":"3","key":"2026100820075572700_cit30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/annonc\/mdz006","article-title":"The Macrophage \u2018Do not Eat Me\u2019 Signal, CD47, is a Clinically Validated Cancer Immunotherapy Target","volume":"30","author":"Takimoto","year":"2019","journal-title":"Ann. Oncol."},{"key":"2026100820075572700_cit31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117396119","article-title":"Mitochondrial Outer Membrane Protein FUNDC2 Promotes Ferroptosis and Contributes to Doxorubicin-Induced Cardiomyopathy","volume":"119","author":"Ta","year":"2022","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"2026100820075572700_cit32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207216","article-title":"Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci."},{"key":"2026100820075572700_cit33","doi-asserted-by":"publisher","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS Nano"},{"key":"2026100820075572700_cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155135","article-title":"Polyphyllin I Induced Ferroptosis to Suppress the Progression of Hepatocellular Carcinoma Through Activation of the Mitochondrial Dysfunction Nrf2\/HO-1\/GPX4 Axis","volume":"122","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"2026100820075572700_cit35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: Alternative Excitation Wavelengths Facilitate Mitochondrial Membrane Potential Cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis."},{"key":"2026100820075572700_cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189234","article-title":"Unveiling Intricating Roles and Mechanisms of Ferroptosis in Melanoma","volume":"1880","author":"Tao","year":"2025","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"5","key":"2026100820075572700_cit37","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","article-title":"Palmitoylation of GPX4 via the Targetable ZDHHC8 Determines Ferroptosis Sensitivity and Antitumor Immunity","volume":"6","author":"Zhou","year":"2025","journal-title":"Nat. Cancer"},{"issue":"1","key":"2026100820075572700_cit38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12935-024-03443-w","article-title":"Activation of the PERK\/eIF2\u03b1 Axis is a Pivotal Prerequisite of Taxanes to Cancer Cell Apoptosis and Renders Synergism to Overcome Paclitaxel Resistance in Breast Cancer Cells","volume":"24","author":"Cai","year":"2024","journal-title":"Cancer Cell Int."},{"key":"2026100820075572700_cit39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156333","article-title":"Artesunate Disrupts Ribosome RNA Biogenesis and Inhibits Ovarian Cancer Growth by Targeting FANCA","volume":"136","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"issue":"24","key":"2026100820075572700_cit40","doi-asserted-by":"publisher","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","article-title":"Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer","volume":"18","author":"Qian","year":"2024","journal-title":"ACS Nano"},{"issue":"4","key":"2026100820075572700_cit41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300806","article-title":"Cancer Nanobombs Delivering Artoxplatin with a Polyigniter Bearing Hydrophobic Ferrocene Units Upregulate PD-L1 Expression and Stimulate Stronger Anticancer Immunity","volume":"11","author":"Gao","year":"2024","journal-title":"Adv. Sci."},{"key":"2026100820075572700_cit42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101349","article-title":"AMPK\u03b12 Attenuates Doxorubicin Induced Ferroptosis by Promoting NCOA4 Degradation in Triple Negative Breast Cancer","volume":"85","author":"Liu","year":"2026","journal-title":"Drug Resistance Updates"},{"issue":"1","key":"2026100820075572700_cit43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","article-title":"Nanoscale Coordination Polymers Induce Immunogenic Cell Death by Amplifying Radiation Therapy Mediated Oxidative Stress","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["ACS Applied Materials &amp; Interfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsami.6c13085","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/37\/50555\/68467608\/am-2026-13085r.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/37\/50555\/68467608\/am-2026-13085r.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:10:10Z","timestamp":1791533410000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aamick\/article\/18\/37\/50555\/5427461\/Functionalized-Red-Blood-Cell-Membrane"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":43,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2026,9,10]]},"published-print":{"date-parts":[[2026,9,23]]}},"URL":"https:\/\/doi.org\/10.1021\/acsami.6c13085","relation":{},"ISSN":["1944-8244","1944-8252"],"issn-type":[{"value":"1944-8244","type":"print"},{"value":"1944-8252","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}